George R. Aylward
Analyst · Steven Schwartz of Raymond James & Associates
Good question. I mean, we generally focus on multiple products at any point in time. So just looking at the fourth quarter where our best selling product was the Emerging Market Fund. But to be honest, you don't need to spend a lot of time talking about one of the best-performing Emerging Market Funds. So in that quarter, we did $1.7 billion of net flows. Then in the first quarter, upon first day of January, announcing that there's going to be a closure on the EM fund. You see a rush of people getting into the funds so that they can continue to have access. But even in the first quarter, if you exclude any benefit from EM, which was huge, the sales of all of the non-EM products were actually greater than the -- and the net flows were actually greater than the fourth quarter. So that is the illustration that the wholesalers, who always focus on multiple products, in some ways had a great opportunity to now start talking about other things as they continue to focus away from the attention that they were paying on the EM side. Our issue, I think, as we tried to illustrate before, is we have too many things to sell as opposed to we have too few things to sell. But we do think the environment as well as our efforts are making things like the senior floating rate, the dynamic AlphaSector continuing to make Multi-Sector Short Term Bond Fund and all still very attractive in this environment. So for us, we really have sort of have to look where the demand is in the market and given a certain cycle and flows and our broad-enough menu, we'll just sort of make sure we have something that matches up to that. So a combination of what we do from a sales execution standpoint but it's really just mirroring up to where is the demand emerging and to Michael's earlier question, sort of where are people on the risk appetite continue on in terms of what they're looking to access. But we have a large number of very attractive, high-performance products on both the defensive side as well as on the higher end of the risk spectrum. And I think that's -- that's one of the reasons why again, we were effectively able to replace the sales of our best-selling fund in the fourth quarter with other flows in the first quarter.
Steven D. Schwartz - Raymond James & Associates, Inc., Research Division: Okay. Just to beat this horse one more time, the effect of this though -- you've got the sales, which is great. The inflows, the effect of this though I would presume without going and looking it up, would be that there would be some headwind on the effective fee rate? As you transfer from the Emerging Markets to these other funds?